A Safety Study Assessing Oral Anticoagulation With Apixaban Versus Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Apixaban (Primary) ; Phenprocoumon
- Indications Atrial fibrillation; Renal failure; Stroke
- Focus Therapeutic Use
- Acronyms AXADIA
- 05 Apr 2017 Planned End Date changed from 1 Feb 2019 to 1 Apr 2019.
- 05 Apr 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2018.
- 05 Apr 2017 Planned initiation date changed from 1 Jan 2017 to 1 Apr 2017.